March 20 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK:
RECOMMENDED PAYMENT OF A FINAL DIVIDEND OF HK4 CENTS PER SHARE FOR YEAR
FY PROFIT ATTRIBUTABLE RMB3.50 BILLION
FY REVENUE RMB28.87 BILLION
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))